Benign prostatic hypertrophy: Difference between revisions

From IDWiki
(Created page with " ==Management== * Non-pharmacologic management: ** Avoid fluids before bedtime or going out ** Decrease caffeine and alcohol intake ** Double voiding to empty the bladder more...")
 
No edit summary
 
Line 5: Line 5:
 
** Decrease caffeine and alcohol intake
 
** Decrease caffeine and alcohol intake
 
** Double voiding to empty the bladder more completely
 
** Double voiding to empty the bladder more completely
* First-line medications include alpha-1 blockers
+
* First-line medications are alpha-1 blockers
 
** [[Tamsulosin]] 0.4 mg p.o. daily, 30 minutes after a meal
 
** [[Tamsulosin]] 0.4 mg p.o. daily, 30 minutes after a meal
 
*** Can be increased to 0.8 mg p.o. daily if no response after 2 to 4 weeks
 
*** Can be increased to 0.8 mg p.o. daily if no response after 2 to 4 weeks
 
** [[Silodosin]] 8 mg p.o. daily
 
** [[Silodosin]] 8 mg p.o. daily
 
** [[Alfuzosin]] 10 mg p.o. daily
 
** [[Alfuzosin]] 10 mg p.o. daily
  +
* Second-line medications include:
  +
** 5-alpha-reductase inhibitors (5-ARIs):
  +
*** [[Dutasteride]] 0.5 mg p.o. daily
  +
*** [[Finasteride]] 5 mg p.o. daily
  +
** PDE-5 inhibitors: [[tadalafil]] 5 mg p.o. daily
  +
** Beta-3 adrenergic agonists: [[mirabegron]] 25 mg p.o daily, can increase to 50 mg after 4 weeks
  +
** Anticholinergics:
  +
*** [[Tolterodine]] IR 1 to 2 mg p.o. twice daily or ER 2 to 4 mg p.o. daily
  +
*** [[Oxybutynin]] IR 5 mg p.o. bid to tid, or ER 5 to 10 mg p.o. daily
  +
*** [[Solifenacin]] 5 mg p.o. daily, can increase to 10 mg after 2 weeks
   
 
[[Category:Urology]]
 
[[Category:Urology]]

Latest revision as of 15:31, 20 February 2023

Management

  • Non-pharmacologic management:
    • Avoid fluids before bedtime or going out
    • Decrease caffeine and alcohol intake
    • Double voiding to empty the bladder more completely
  • First-line medications are alpha-1 blockers
    • Tamsulosin 0.4 mg p.o. daily, 30 minutes after a meal
      • Can be increased to 0.8 mg p.o. daily if no response after 2 to 4 weeks
    • Silodosin 8 mg p.o. daily
    • Alfuzosin 10 mg p.o. daily
  • Second-line medications include:
    • 5-alpha-reductase inhibitors (5-ARIs):
    • PDE-5 inhibitors: tadalafil 5 mg p.o. daily
    • Beta-3 adrenergic agonists: mirabegron 25 mg p.o daily, can increase to 50 mg after 4 weeks
    • Anticholinergics:
      • Tolterodine IR 1 to 2 mg p.o. twice daily or ER 2 to 4 mg p.o. daily
      • Oxybutynin IR 5 mg p.o. bid to tid, or ER 5 to 10 mg p.o. daily
      • Solifenacin 5 mg p.o. daily, can increase to 10 mg after 2 weeks